Immuron (IMRN) Operating Leases (2019 - 2022)
Immuron (IMRN) posted quarterly Operating Leases of $148156.8 for Q2 2022, up 923.45% year-on-year from $14476.2 in Q2 2021, and up 923.45% on a QoQ basis from $14476.2 in Q2 2021.
Immuron (IMRN) Operating Leases (2019 - 2022) Analysis & Trends
Immuron (IMRN) has reported Operating Leases for 4 consecutive years, with $148156.8 the latest figure, recorded in Q2 2022.
- Quarterly Operating Leases rose 923.45% year-over-year to $148156.8 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $148156.8 (up 923.45% YoY) and the FY2022 annual result came in at $148156.8, up 923.45% from the prior year.
- Operating Leases climbed to $148156.8 in Q2 2022 per IMRN's latest filing, from $14476.2 in the prior quarter.
- Over the last five years, Operating Leases for IMRN reached as high as $148156.8 in Q2 2022 and fell as low as $14476.2 in Q2 2021.
- A 4-year average of $71483.7 and a median of $61650.9 in 2019 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases sank 66.45% — and 2022, when it soared 923.45%.
- Year by year, Operating Leases stood at $80148.0 in 2019, then slumped by 46.16% to $43153.9 in 2020, then plunged by 66.45% to $14476.2 in 2021, then surged by 923.45% to $148156.8 in 2022.
- According to Business Quant data, Operating Leases over the past three periods registered $148156.8, $14476.2, and $43153.9 for Q2 2022, Q2 2021, and Q2 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 148,156.76 |
| Jun 30, 2021 | 14,476.19 |
| Jun 30, 2020 | 43,153.86 |
| Dec 31, 2019 | 80,148.00 |